← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Besilesomab currently has availability issues reported in 6 European registers: Austria, Germany, Greece, Ireland, Italy, Sweden.
Shortage ATC V09HA03 · also listed as: BESILESOMAB · data refreshed 10 September 2026
As of 10 September 2026, 6 of the 9 tracked registers list current availability issues for Besilesomab, covering 6 affected product presentations. The longest-running open report was filed in Austria on 2025-09-10 and has now been open for about 12 months. Where agencies state a cause, manufacturing problems lead with 3 of the 3 stated-cause reports. The furthest expected-resolution date currently on file is 2028-06-26; the earliest is 2028-06-26. The issue spread across registers over time rather than at once: Austria reported first (2025-09-10), with Greece following roughly 9 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Ireland, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Besilesomab is coded V09HA03 — a medicine acting on various — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Scintimun 1 mg Kit für ein radioaktives Arzneimittel | 2025-09-10 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Scintimun + 1 more productsScintimun | 2025-09-17 | 2028-06-26 | Probleme in der Herstellung Alternatives: EFDEGE 1 GBq/ml, Injektionslösung - Einreichungsnummer: 2159726 | register ↗ |
| 🇬🇷 Greece | Limited availability Besilesomab | 2026-06-10 | 2028-06-26 | ουσία | register ↗ |
| 🇮🇪 Ireland | Shortage Scintimun 1 mg kit for radiopharmaceutical preparation EU/1/09/602/001 T | 2025-09-17 | 2028-06-26 | Manufacturing delay (Multiple countries) Alternatives: Alternative(s) available — see the national register. | register ↗ |
| 🇮🇹 Italy | Shortage SCINTIMUN | 2025-09-17 | 2028-06-26 | Problemi produttivi Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
| 🇸🇪 Sweden | Shortage Scintimun 1 mg Beredningssats för radioaktivt läkemedel | 2025-09-17 | 2028-06-26 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Besilesomab in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | Besilesomab | Limited availability | 2026-06-10 | 2028-06-26 | ουσία |
| 🇩🇪 DE | Scintimun | Shortage | 2025-09-17 | 2028-06-26 | Probleme in der Herstellung |
| 🇩🇪 DE | Scintimun | Resolved | 2025-09-17 | 2026-06-26 | Probleme in der Herstellung |
| 🇮🇪 IE | Scintimun 1 mg kit for radiopharmaceutical preparation EU/1/09/602/001 | Shortage | 2025-09-17 | 2028-06-26 | Manufacturing delay (Multiple countries) |
| 🇮🇹 IT | SCINTIMUN | Shortage | 2025-09-17 | 2028-06-26 | Problemi produttivi |
| 🇸🇪 SE | Scintimun 1 mg Beredningssats för radioaktivt läkemedel | Shortage | 2025-09-17 | 2028-06-26 | |
| 🇦🇹 AT | Scintimun 1 mg Kit für ein radioaktives Arzneimittel | Shortage | 2025-09-10 | — |
Yes. As of 10 September 2026, availability issues are reported in: Austria, Germany, Greece, Ireland, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2028-06-26 to 2028-06-26. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Besilesomab: BASG (Austria), BfArM (Germany), EOF limited-availability list (Greece), HPRA (Ireland), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Besilesomab — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/besilesomab/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Besilesomab availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/besilesomab/">Besilesomab shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>